CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Quercetin ProphylaxisWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug922 Quercetin Treatment Wiki 1.00
drug286 Colchicine Wiki 0.45

Correlated MeSH Terms (4)

Name (Synonyms) Correlation
D011024 Pneumonia, Viral NIH 0.14
D011014 Pneumonia NIH 0.07
D045169 Severe Acute Respiratory Syndrome NIH 0.06
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.07

There is one clinical trial.

Clinical Trials

1 The Possible Effect of Quercetin on Prophylaxis and Treatment of COVID-19

Novel Coronavirus is defined to be the cause of COVID-19, recently. It's known that COVID-19 goes with excessive immune reaction of human body in severe cases. The investigators hypothesize that quercetin, as a strong scavenger and anti-inflammatory agent, can be effective on both prophylaxis and treatment of COVID-19 cases. Therefore, the aim of this study to evaluate the possible role of quercetin on prophylaxis and treatment of COVID-19.

NCT04377789 COVID-19 Dietary Supplement: Quercetin Prophylaxis Dietary Supplement: Quercetin Treatment

Primary Outcomes

Description: Prevalence of COVID-19 in prophylaxis and sham group will be calculated using a questionnaire including hospital records

Measure: Prevalence of COVID-19 calculated using a questionnaire

Time: 3 months

Description: Mortality rate will be compared between two groups

Measure: Standardized Mortality rate

Time: 3 months

Secondary Outcomes

Description: Morbidity rates besides recovery rates from COVID-19 will be documented

Measure: Morbidity rate

Time: 3 months

No related HPO nodes (Using clinical trials)